Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Management of Fetal and Neonatal Graves’ Disease
source: Hormone Research in Pædiatrics
year: 2017
authors: Léger J
summary/abstract:Fetal and neonatal autoimmune hyperthyroidism is a rare, serious but transient disorder. Early diagnosis and treatment are key objectives for an optimal prognosis and the well-being of the child. This review focuses on the management of these patients during the fetal and neonatal periods. We propose a diagnostic algorithm for high-risk pregnancies in mothers with current or past hyperthyroidism related to Graves’ disease, involving repeated fetal thyroid gland assessments from 20 weeks of gestation onwards and maternal serum thyroid-stimulating hormone receptor antibody (TRAb) determination, with close monitoring if TRAb levels exceed 2 to 3 times the upper limit of the normal range.
In fetuses with goiter, the main clinical issue is determining whether the cause is maternal antithyroid drug (ATD) treatment that is appropriate for achieving normal maternal thyroid function but inappropriate and excessive for the fetus, resulting in hypothyroidism and necessitating a decrease in the ATD dose during pregnancy, or the presence of TRAbs resulting in fetal thyroid stimulation and hyperthyroidism, requiring an increase in the maternal ATD dose.
Methimazole/carbimazole treatment should be initiated as soon as possible during the neonatal period, carefully managed and maintained over a period of 1-3 months and then stopped when TRAb is no longer detectable in serum.
organization: Hôpital Robert Debré, France; Université Paris Diderot, France; Sorbonne Paris Cité, France; Institut National de la Santé et de la Recherche Médicale (INSERM), FranceDOI: 10.1159/000453065
read more full text
myBinderRelated Content
-
Efficacy of Orbital Radiotherapy in Moderate-to-Severe Active Graves’ Orbitopathy Including Long-Lasting Disease: ...Background: We aimed to explore the eff...
-
Efficacy and Safety of Immunosuppressive Agents for Thyroid Eye DiseasePurpose: To present an update on the ef...
-
Symptoms Strongly Drive the Consideration of Alternative Thyroid Hormone-Replacement Options in Patients With Hypoth...The standard treatment for hypothyroidis...
-
Graves’ Disease Treatment for Someone in Their 20sHyperthyroidism triggered by Graves’ d...
-
PREGO (Presentation of Graves’ Orbitopathy) Study: Changes in Referral Patterns to European Group On Graves...Background/Aims: The epidemiology of Gr...
-
Trial of Rituximab for Graves’ OphthalmopathyBrief Summary: This study is being done...
-
Association of Radioactive Iodine Treatment With Cancer Mortality in Patients With HyperthyroidismImportance Radioactive iodine (RAI) h...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Brought to you by
Supported through an independent
educational grant by
Facebook
Google